<DOC>
	<DOCNO>NCT02610426</DOCNO>
	<brief_summary>This research trial study whole exome sequence find causative variant germline deoxyribonucleic acid ( DNA ) sample patient congestive heart failure receive therapy breast cancer . Studying sample germline DNA laboratory patient congestive heart failure receive therapy breast cancer may help doctor learn change occur DNA identify biomarkers related congestive heart failure .</brief_summary>
	<brief_title>Whole Exome Sequencing Finding Causative Variants Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy Breast Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To identify , use next generation sequencing , rare variant large effect size impact risk congestive heart failure ( CHF ) patient clinical trial ECOG-5103 ( E5103 ) . OUTLINE : Previously collect germline DNA sample analyze via whole exome sequencing .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>European American patient DNA available European American patient develop CHF patient develop CHF follow full course treatment anthracycline bevacizumab African American case ( base drop leave ventricular ejection fraction [ LVEF ] &lt; 50 drop baseline &gt; 20 point ) African American control</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>